Pacira BioSciences price target raised to $36.50 by Truist
Truist Securities raised its price target on Pacira BioSciences to $36.50 from $31.00, per Benzinga ratings coverage.
Truist Securities raised its price target on Pacira BioSciences to $36.50 from $31.00, per Benzinga ratings coverage.